Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German pharmaceutical ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Two European-headquartered drugmakers told Reuters this week they are sending as much of their medicines across the Atlantic ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

MADRID (Reuters) -Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it ...

Introduction Pharma 4.0 refers to the digital transformation of pharmaceutical manufacturing, integrating advanced technologies such as AI, IoT ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...

Rigel Pharmaceuticals is now reporting net income and has three marketed drugs, all of which can continue to grow. Read more ...

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...